Gelteq LTD (GELS) — SEC Filings
Latest SEC filings for Gelteq LTD. Recent 6-K filing on Mar 24, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
Overview
Gelteq LTD (GELS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Mar 24, 2026: This 6-K filing from Gelteq Ltd, a foreign issuer, simply confirms the company's basic identifying information and the filing date of March 24, 2026. It provides their mailing and business address in South Melbourne, VIC, Australia, and lists their CIK as 0001920092. This filing doesn't contain any
Sentiment Summary
Across 7 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 5 neutral. The dominant filing sentiment for Gelteq LTD is neutral.
Filing Type Overview
Gelteq LTD (GELS) has filed 5 6-K, 2 20-F with the SEC between Oct 2024 to Mar 2026.
Filings by Year
Recent Filings (7)
-
Gelteq Ltd Files Routine 6-K, No New Material Info
— 6-K · Mar 24, 2026
This 6-K filing from Gelteq Ltd, a foreign issuer, simply confirms the company's basic identifying information and the filing date of March 24, 2026. It provide -
Gelteq Ltd. to Host Investor Presentation
— 6-K · Dec 9, 2025 Risk: low
On December 9, 2025, Gelteq Limited will host a virtual presentation for private investors, organized by Investor Summit. A copy of the presentation materials i -
Gelteq Faces Going Concern Doubt Amidst Mounting Losses, Seeks New Capital
— 20-F · Nov 17, 2025 Risk: high
Gelteq Ltd (GELS) reported a history of operating losses since its inception in October 2018 and anticipates continued losses for the foreseeable future, as det -
Gelteq Ltd Files 6-K with H1 2024 Financials
— 6-K · Jun 30, 2025 Risk: low
Gelteq Limited filed a Form 6-K on June 30, 2025, reporting its unaudited financial results for the six months ended December 31, 2024. The company, previously -
Gelteq Secures $50M Purchase Agreement with Lincoln Park Capital
— 6-K · Mar 14, 2025 Risk: medium
On March 13, 2025, Gelteq Limited entered into a Purchase Agreement and a Registration Rights Agreement with Lincoln Park Capital Fund, LLC. Under these agreeme -
Gelteq Ltd. Files 2024 Annual Report
— 20-F · Nov 15, 2024 Risk: low
Gelteq Ltd. filed its annual report on Form 20-F for the fiscal year ended June 30, 2024. The company, previously known as Gelteq Pty Ltd. until March 28, 2022, -
Gelteq Ltd Completes $5.2M IPO
— 6-K · Oct 30, 2024 Risk: medium
On October 30, 2024, Gelteq Limited (the "Company") completed its initial public offering (IPO) of 1,300,000 ordinary shares at $4.00 per share. This generated
Risk Profile
Risk Assessment: Of GELS's 6 recent filings, 1 were flagged as high-risk, 2 as medium-risk, and 3 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Nathan J. Givoni
Industry Context
Gelteq operates in the innovative gel products sector, a nascent market with unproven demand. The competitive landscape is characterized by the need for significant R&D investment and regulatory hurdles. Success hinges on differentiating novel product offerings and achieving market penetration against established or emerging alternatives.
Top Tags
financing (2) · administrative (1) · foreign-issuer (1) · compliance (1) · investor-relations (1) · presentation (1) · Going Concern (1) · Operating Losses (1) · Biotechnology (1) · Early Stage Company (1)
Key Numbers
- Ordinary Shares Outstanding: 10,711,059 — As of November 13, 2025, indicating the current share count.
- Incorporation Date: October 15, 2018 — Marks the inception of Gelteq Ltd, providing context for its operating history.
- Fiscal Year End: June 30, 2025 — The period covered by this annual report, crucial for financial analysis.
- Purchase Commitment: $50.0M — Maximum amount Lincoln Park Capital Fund, LLC has committed to purchase in ordinary shares.
- Purchase Period: 36 months — The duration over which the purchase agreement is effective.
- SEC File Number: 001-42373 — Identifies the company's filings with the SEC.
- Gross IPO Proceeds: $5.2M — Capital raised by Gelteq Limited from its initial public offering.
- Shares Offered: 1.3M — The total number of ordinary shares sold in the IPO.
- Price Per Share: $4.00 — The offering price for each ordinary share in the IPO.
Frequently Asked Questions
What are the latest SEC filings for Gelteq LTD (GELS)?
Gelteq LTD has 7 recent SEC filings from Oct 2024 to Mar 2026, including 5 6-K, 2 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of GELS filings?
Across 7 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 5 neutral. The dominant sentiment is neutral.
Where can I find Gelteq LTD SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Gelteq LTD (GELS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Gelteq LTD?
Financial highlights for Gelteq LTD are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for GELS?
The investment thesis for GELS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Gelteq LTD?
Key executives identified across Gelteq LTD's filings include Nathan J. Givoni.
What are the main risk factors for Gelteq LTD stock?
Of GELS's 6 assessed filings, 1 were flagged high-risk, 2 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Gelteq LTD?
Forward guidance and predictions for Gelteq LTD are extracted from SEC filings as they are enriched.